If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email firstname.lastname@example.org.
Please tell us what format you need. It will help us if you say what assistive technology you use.
This technology relates to a mutated Francisella bacterium, wherein the ggt gene is silenced or deleted. The ggt gene is a well-characterised target, which should aid licensing of an attenuated Francisella vaccine.
You can read guidance for organisations on how to find out about and access Dstl-owned intellectual property available under the Easy Access IP scheme.